HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors
NCT04979000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49
Last updated 2025-09-22
Summary
This is a case-control study designed to evaluate the role of anatomic site, gender and race in human papillomavirus-associated head and neck squamous cell cancers (HNSCC). We will explore the role of HPV, tobacco, alcohol and drug use, in HNSCC by tumor site with particular emphasis on the sinonasal cavity as well as differences in risk factors for HPV-positive HNSCC by gender and race.
Conditions
- Sinonasal Carcinoma
- HPV-Related Squamous Cell Carcinoma
Sponsors & Collaborators
- collaborator INDUSTRY
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
lead OTHER
Principal Investigators
-
Nyall London, M.D. · Department of Otolaryngology and Surgery
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-03
- Primary Completion
- 2025-05-28
- Completion
- 2025-05-28
Countries
- United States
Study Locations
More Related Trials
-
Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380 ·Status: UNKNOWN ·Phase: NA
-
Human Papillomavirus and Oropharynx Carcinoma
NCT00918710 ·Status: UNKNOWN
-
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
NCT05693116 ·Status: RECRUITING
-
Window Trial 5-aza in HNSCC, T-tare
NCT02178072 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428 ·Status: COMPLETED
-
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
NCT02126189 ·Status: UNKNOWN
-
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
NCT01958515 ·Status: COMPLETED
-
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
NCT05123950 ·Status: COMPLETED
-
Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT05956795 ·Status: TERMINATED
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma
NCT05535023 ·Status: WITHDRAWN ·Phase: PHASE2
-
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
NCT05845632 ·Status: UNKNOWN
-
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
NCT05307939 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
NCT07063212 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
NCT06373380 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
NCT05582590 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
NCT06693323 ·Status: RECRUITING ·Phase: PHASE2
-
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
NCT05280457 ·Status: RECRUITING ·Phase: PHASE2
-
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
NCT01530997 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614 ·Status: RECRUITING ·Phase: PHASE2
-
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease
NCT05048459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT02277197 ·Status: COMPLETED ·Phase: PHASE1
-
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer
NCT05296135 ·Status: WITHDRAWN
-
Changes in the Microenvironment of HPV-induced Head and Neck Cancers in West Indies and Metropolitan Population
NCT03580070 ·Status: COMPLETED
-
Molecular Signatures of HPV+ ORL Cancers (OROPAP)
NCT04189003 ·Status: COMPLETED